Cormorant Asset Management, LP's Form 4 filing
MoonLake Immunotherapeutics (MLTX) · filed Oct 1, 2025
- Accession no.
- 0000929638-25-003712
- Filed
- Oct 1, 2025, 5:22 PM ET
- Trade date
- Sep 29-30, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions and 0 derivative transactions. Open-market sales total $46.9M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cormorant Asset Management, LPCIK 0001583977 | Other: Former 10% Owner |
| Chen BihuaCIK 0001599214 | Other: Former 10% Owner |
| Cormorant Global Healthcare Master Fund, LPCIK 0001618442 | Other: Former 10% Owner |
| Cormorant Private Healthcare Fund II, LPCIK 0001747677 | Other: Former 10% Owner |
| Cormorant Private Healthcare Fund III LPCIK 0001817320 | Other: Former 10% Owner |
| Cormorant Private Healthcare Fund IV LPCIK 0001871297 | Other: Former 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 29, 2025 | Class A Ordinary Shares | SSaleDisposed | −70,748 | $9.38 | −$663,616.24 | 8,423,403 | Indirect | |
| Sep 29, 2025 | Class A Ordinary Shares | SSaleDisposed | −232,460 | $8.40 | −$1,952,664 | 8,190,943 | Indirect | |
| Sep 29, 2025 | Class A Ordinary Shares | SSaleDisposed | −3,390,943 | $7.58 | −$25,703,347.94 | 4,800,000 | Indirect | |
| Sep 29, 2025 | Class A Ordinary Shares | SSaleDisposed | −2,800,000 | $6.61 | −$18,508,000 | 2,000,000 | Indirect | |
| Sep 30, 2025 | Class A Ordinary Shares | SSaleDisposed | −5,827 | $6.96 | −$40,555.92 | 1,994,173 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.